Bill Gianoukos is the CEO and founder of Goodpath, a virtual provider delivering integrative care for chronic conditions. He has spent over a decade building technology-enabled health solutions and working with employers, payers and clinicians to design sustainable benefits programs. His perspective on GLP-1 coverage decisions comes from direct work with self-insured employers navigating the clinical, financial and workforce implications of these therapies.